Vaso-occlusive Crisis clinical trials at UC Health
1 in progress, 0 open to eligible people
A Study of the Safety Of Experimental Medicine Rivipansel (GMI-1070) For Hospitalized Patients With Sickle Cell Disease
Sorry, in progress, not accepting new patients
This is an open label extension study in subjects with Sickle Cell Disease (SCD) who have completed the double blind Phase 3 study (B5201002).
at UC Davis UCSF